SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001731122-24-001573
Filing Date
2024-10-09
Accepted
2024-10-09 17:00:44
Documents
15
Period of Report
2024-10-04
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A e6017_8-ka.htm   iXBRL 8-K/A 34211
2 EXHIBIT 17.1 e6017_ex17-1.htm EX-17.1 11859
3 GRAPHIC image_002.jpg GRAPHIC 3030
  Complete submission text file 0001731122-24-001573.txt   235923

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE vrpx-20241004.xsd EX-101.SCH 3027
5 XBRL LABEL FILE vrpx-20241004_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE vrpx-20241004_pre.xml EX-101.PRE 24173
17 EXTRACTED XBRL INSTANCE DOCUMENT e6017_8-ka_htm.xml XML 4479
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-4597
Virpax Pharmaceuticals, Inc. (Filer) CIK: 0001708331 (see all company filings)

IRS No.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-40064 | Film No.: 241363223
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)